细胞库外包市场规模、份额和成长分析（按类型、产品、细胞类型、阶段和地区划分）－2026-2033年产业预测

预计到 2024 年，全球细胞库外包市场规模将达到 155.9 亿美元，到 2025 年将达到 182.7 亿美元，到 2033 年将达到 650.4 亿美元，预测期（2026-2033 年）的复合年增长率为 17.2%。

全球细胞库外包市场预计将迎来显着成长，这主要得益于冷冻保存技术和细胞库製备调查方法的进步。干细胞疗法日益普及以及对单株抗体和高效的生物製药需求的不断增长，是推动该市场发展的重要因素。此外，政府的支持性政策以及细胞株保存和鑑定技术的进步也为市场成长注入了动力。主要产业参与者之间的重要合作，尤其是在研发领域的合作，预计将进一步加速市场成长。对用于提高组织在冷冻保存过程中稳定性的冷冻保护剂的研究，预计也将对市场格局产生正面影响。总而言之，这些因素已使细胞库外包成为生物製药领域的关键组成部分。

推动全球细胞库外包市场发展的因素

推动全球细胞库外包市场发展的关键因素之一是干细胞疗法日益普及的现象。干细胞疗法因其能够治疗多种疾病和病症，在再生医学领域备受关注。随着人们对这些治疗方法的兴趣日益增长，对可靠、高品质细胞株的需求也随之增加，从而导致对细胞库服务的需求不断增长。这一趋势正在推动细胞库外包产业的成长，因为生物製药公司和受託研究机构(CRO) 正在寻求高效且经济的方式来生产和保存这些关键细胞株，以满足不断增长的治疗需求。

全球细胞库外包市场的限制因素

全球细胞库外包市场面临的一大挑战是细胞库服务的高成本。细胞库流程的复杂性要求进行全面的测试和鑑定，以确保细胞株的安全性和质量，这导致对专用基础设施和设备的大量投资。此外，监管机构对细胞株生产和储存的严格规定也推高了成本。这种经济负担可能会阻碍细胞库服务的广泛应用，尤其是在医疗预算有限的发展中地区，这限制了人们获得这些重要服务的机会。

全球细胞库外包市场趋势

受个人化医疗需求不断增长的推动，全球细胞库外包市场呈现显着的成长趋势。随着医疗保健产业向基于个别基因谱的客製化治疗模式转变，细胞库外包服务在提供满足患者特定需求的客製化细胞产品方面发挥关键作用。该领域的企业正在加速采用先进技术，旨在提高基因匹配细胞的生产效率并促进标靶治疗。这种对个人化治疗的关注不仅提升了细胞库在临床应用中的重要性，也刺激了创新和投资，使市场能够顺应不断发展的医疗保健模式，实现显着成长。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球细胞库外包市场规模（按类型和复合年增长率划分）（2026-2033 年）

• 主细胞库
• 病毒细胞库
• 工作细胞库

全球细胞库外包市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 脐带血细胞库
• 成人干细胞库
• 诱导性多功能干细胞库
• 胚胎干细胞库

全球细胞库外包市场规模（依细胞类型划分）及复合年增长率（2026-2033 年）

• 干细胞
  • 脐带血库
  • 胚胎干细胞库
  • 成人干细胞库
  • 牙髓干细胞库
  • iPS细胞库
• 非干细胞

全球细胞库外包市场规模按阶段和复合年增长率划分（2026-2033 年）

• 银行储存
  • 主细胞库保存
  • 工作细胞库保存
  • 细胞储存稳定性测试
• 细胞储存稳定性测试
• 银行准备
  • 主细胞库製备
  • 细胞库准备
• 银行特征分析与测试
  • 安全测试
  • 病毒细胞库
  • 微生物细胞库
  • 基因表现检测
  • 核形态学检查
  • 基因序列测定检测

全球细胞库外包市场规模（按地区划分）及复合年增长率（2026-2033 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Charles River Laboratories（USA）
• Lonza（Switzerland）
• Merck KGaA（Germany）
• SGS Societe Generale de Surveillance SA（Switzerland）
• Cryo-Cell International, Inc.（USA）
• LifeCell（India）
• WuXi AppTec（China）
• Eurofins Scientific（Luxembourg）
• Sartorius（Bio Outsource）（Germany）
• BSL Bioservice（Germany）
• Key Developments
• ViaCord（USA）
• StemCyte, Inc.（USA）
• Cryoviva Biotech Pvt. Ltd.（India）

结论与建议

Global Cell Banking Outsourcing Market size was valued at USD 15.59 Billion in 2024 and is poised to grow from USD 18.27 Billion in 2025 to USD 65.04 Billion by 2033, growing at a CAGR of 17.2% during the forecast period (2026-2033).

The global cell banking outsourcing market is poised for substantial growth, fueled by advancements in cryopreservation techniques and cell bank preparation methodologies. Increasing popularity of stem cell therapies, alongside the rising demand for monoclonal antibodies and effective biopharmaceuticals, significantly enhances this market. Furthermore, supportive government policies and technological innovations in cell line storage and characterization contribute to the momentum. Noteworthy collaborations among key players in the industry, particularly in research and development, are anticipated to further accelerate growth. The exploration of cryoprotective agents for improved tissue stability during cryopreservation also stands to positively influence the market landscape. Overall, the confluence of these factors positions cell banking outsourcing as a vital segment within the biopharmaceutical sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Banking Outsourcing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Banking Outsourcing Market Segments Analysis

Global Cell Banking Outsourcing Market is segmented by Type, Product, Cell Type, Phase and region. Based on Type, the market is segmented into Master Cell Banking, Viral Cell Banking and Working Cell Banking. Based on Product, the market is segmented into Cord Cell Banking, Adult Stem Cell Banking, Induced Pluripotent Stem Cell Banking and Embryonic Stem Cell Banking. Based on Cell Type, the market is segmented into Stem Cell and Non-Stem Cell. Based on Phase, the market is segmented into Bank Storage, Cell Storage Stability Testing, Bank Preparation and Bank Characterization and Testing. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cell Banking Outsourcing Market

A significant factor propelling the global cell banking outsourcing market is the heightened adoption of stem cell therapies, which are gaining traction in the realm of regenerative medicine due to their capability to address various diseases and disorders. As interest in these therapies escalates, so does the necessity for reliable and high-quality cell lines, consequently amplifying the demand for cell banking services. This trend stimulates the growth of the cell banking outsourcing sector, as biopharmaceutical companies and contract research organizations (CROs) look for efficient and cost-effective means to produce and preserve these essential cell lines, ensuring they meet the increasing therapeutic needs.

Restraints in the Global Cell Banking Outsourcing Market

A prominent challenge facing the global cell banking outsourcing market is the elevated expense associated with cell banking services. The intricate nature of the cell banking process necessitates comprehensive testing and characterization to guarantee the safety and quality of cell lines, leading to substantial investment in specialized infrastructure and equipment. Furthermore, the stringent regulations enforced by authorities regarding the production and storage of cell lines contribute to increased costs. This financial burden can hinder the widespread adoption of cell banking services, particularly in developing regions where healthcare budgets are constrained, thereby limiting access to these essential services.

Market Trends of the Global Cell Banking Outsourcing Market

The Global Cell Banking Outsourcing market is experiencing a significant trend driven by the escalating demand for personalized medicine. As healthcare shifts towards tailoring treatments to individual genetic profiles, cell banking outsourcing services are pivotal in providing customized cellular products that align with these unique patient needs. Companies in this sector are increasingly adopting advanced technologies aimed at enhancing the production of genetically matched cells, thereby facilitating targeted therapies. This focus on individualized treatment not only boosts the relevance of cell banks in clinical applications but also fosters innovation and investment, positioning the market for substantial growth in response to evolving healthcare paradigms.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cell Banking Outsourcing Market Size by Type & CAGR (2026-2033)

• Market Overview
• Master Cell Banking
• Viral Cell Banking
• Working Cell Banking

Global Cell Banking Outsourcing Market Size by Product & CAGR (2026-2033)

• Market Overview
• Cord Cell Banking
• Adult Stem Cell Banking
• Induced Pluripotent Stem Cell Banking
• Embryonic Stem Cell Banking

Global Cell Banking Outsourcing Market Size by Cell Type & CAGR (2026-2033)

• Market Overview
• Stem Cell
  • Cord Cell Banking
  • Embryonic Stem Cell Banking
  • Adult Stem Cell Banking
  • Dental Stem Cell Banking
  • IPS Stem Cell Banking
• Non-Stem Cell

Global Cell Banking Outsourcing Market Size by Phase & CAGR (2026-2033)

• Market Overview
• Bank Storage
  • Master Cell Bank Storage
  • Working Cell Bank Storage
  • Cell Storage Stability Testing
• Cell Storage Stability Testing
• Bank Preparation
  • Master Cell Bank Preparation
  • Working Cell Bank Preparation
• Bank Characterization and Testing
  • Safety Testing
  • Viral Cell Banks
  • Microbial Cell Banks
  • Gene Expression Testing
  • Karyology Testing
  • Gene Sequencing Testing

Global Cell Banking Outsourcing Market Size & CAGR (2026-2033)

• North America (Type, Product, Cell Type, Phase)
  • US
  • Canada
• Europe (Type, Product, Cell Type, Phase)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, Cell Type, Phase)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, Cell Type, Phase)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, Cell Type, Phase)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS Societe Generale de Surveillance SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cryo-Cell International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeCell (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius (Bio Outsource) (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BSL Bioservice (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
• Key Developments
• ViaCord (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• StemCyte, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cryoviva Biotech Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations